Best peptides for Weight Loss

GLP-1 receptor agonist | Type 2 diabetes management

Semaglutide is a synthetic analog of glucagon-like peptide-1 (GLP-1), a hormone involved in glucose metabolism and appetite regulation. As a GLP-1 receptor agonist, semaglutide enhances insulin secretion in response to elevated blood glucose levels, suppresses glucagon secretion, and slows gastric emptying. These mechanisms contribute to improved glycemic control and increased satiety, making semaglutide a significant option in managing type 2 diabetes and obesity.

Metabolic | Energy production and cellular repair

NAD+ (Nicotinamide adenine dinucleotide) is a crucial coenzyme involved in various metabolic processes, including energy production and cellular repair mechanisms. Recent research highlights its potential roles in protecting against oxidative stress and enhancing therapeutic efficacy in certain cancer treatments.

GLP-1 Agonist | Type 2 Diabetes and Obesity

Orforglipron (LY-3502970) is an investigational oral small-molecule GLP-1 receptor agonist studied for type 2 diabetes and obesity, offering pill-based dosing without injection.

Mitochondrial protection | Heart and neuro health

SS-31, also known as Elamipretide, is a peptide that has garnered attention for its potential role in mitochondrial protection and its implications in various health conditions, particularly those involving oxidative stress and mitochondrial dysfunction.

Triple Agonist | Weight Loss & Diabetes

Triple GLP-1/GIP/Glucagon Agonist | Weight Loss & Diabetes

ERR Agonist | Metabolic Modulator

Synthetic Pan-ERR Agonist | Exercise Mimetic & Metabolic Modulator

Modulation of endothelial function | Vascular health

PE 22-28 is a peptide that has attracted interest for its potential roles in vascular health and metabolic conditions, particularly in the context of gestational diabetes and placental function. The peptide is derived from the sequence of the human protein, and its mechanism of action is thought to involve modulation of endothelial function and inflammatory responses, which are critical in maintaining vascular integrity and metabolic homeostasis.

GLP-1/glucagon agonist | Weight loss

Mazdutide (IBI362) is an investigational dual GLP-1/glucagon receptor agonist studied for weight loss and type 2 diabetes, combining appetite suppression with increased energy expenditure.

Dual Agonist | Obesity and metabolic disorders

Survodutide (BI 456906) is an investigational dual agonist that targets both glucagon-like peptide-1 (GLP-1) and glucagon receptors. This peptide is primarily being studied for its potential in treating obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). The dual action of Survodutide is designed to enhance weight loss while also improving glycemic control, which is particularly relevant for individuals with type 2 diabetes and related metabolic disorders.

GIP/GLP-1 Agonist | Type 2 Diabetes and Obesity

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that has been investigated for its potential in managing type 2 diabetes and obesity. Its unique mechanism of action aims to enhance glycemic control and promote weight loss.

Metabolic regulation | Male fertility

MOTS-C is a mitochondrial-derived peptide that plays a significant role in metabolic regulation and cellular stress responses. It has been implicated in various health conditions, including diabetic nephropathy, cardiovascular diseases, and placental function. The peptide is believed to exert its effects through several mechanisms, including modulation of mitochondrial function, regulation of cellular metabolism, and influencing stress response pathways.

Somatostatin analog | Management of acromegaly

Research peptide discovered via AI researcher. peptide-based therapeutic

KISS1R activation | Fertility and reproductive health

Kisspeptin (KP-10) is a decapeptide derived from the KISS1 gene, known for its role in the regulation of the hypothalamic-pituitary-gonadal (HPG) axis. It primarily functions by activating the KISS1 receptor (KISS1R), which stimulates the release of gonadotropin-releasing hormone (GnRH). This cascade is crucial for the regulation of reproductive hormones, including luteinizing hormone (LH) and follicle-stimulating hormone (FSH), thereby influencing fertility and reproductive health.

Fatty acid transport | Metabolic health

L-Carnitine (levocarnitine) is an amino acid derivative that shuttles long-chain fatty acids into mitochondria for energy production, studied for metabolic, cardiovascular, and exercise performance applications.

GLP-1 receptor agonist | Diabetes management

Liraglutide is a synthetic analog of human glucagon-like peptide-1 (GLP-1), which is integral to glucose metabolism and appetite regulation. As a GLP-1 receptor agonist, liraglutide enhances insulin secretion in response to elevated blood glucose levels while inhibiting glucagon release, thereby contributing to lower blood sugar levels. Additionally, it slows gastric emptying and promotes feelings of fullness, which can aid in weight loss for individuals with obesity or type 2 diabetes.

GnRH Agonist | Prostate cancer treatment

Research peptide discovered via AI researcher. peptide-based therapeutic

Inhibition | Weight loss and metabolic regulation

Tesofensine is a synthetic compound that was originally developed as an antidepressant but has gained attention for its potential applications in weight management and metabolic regulation. Its primary mechanism of action involves the inhibition of the reuptake of key neurotransmitters, including serotonin, norepinephrine, and dopamine. This inhibition may lead to reduced appetite and increased energy expenditure, thereby contributing to weight loss and improved energy balance.

GLP-1 Agonist | Type 2 Diabetes Management

Research peptide discovered via AI researcher. peptide-based therapeutic

Amylin analog | Obesity and type 2 diabetes

Cagrilintide (AM833) is a long-acting amylin analog investigated for once-weekly subcutaneous use in obesity and type 2 diabetes, most notably combined with semaglutide as CagriSema.

GLP-1 Agonist | Type 2 Diabetes Management

Dulaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that is used primarily for the treatment of type 2 diabetes. It mimics the action of the endogenous GLP-1 hormone, which is involved in glucose metabolism. The mechanism of action includes stimulating insulin secretion in response to elevated blood glucose levels, inhibiting glucagon release, and slowing gastric emptying, which collectively contribute to improved glycemic control and potential weight loss.

GLP-1 Agonist | Type 2 Diabetes Management

Exenatide is a synthetic peptide that mimics the action of glucagon-like peptide-1 (GLP-1), a hormone involved in glucose metabolism. It functions primarily as a GLP-1 receptor agonist, promoting insulin secretion in response to elevated blood glucose levels, inhibiting glucagon release, and slowing gastric emptying. These mechanisms contribute to improved glycemic control in patients with type 2 diabetes and may also aid in weight management due to its appetite-suppressing effects.

MC4R Agonist | Genetic obesity treatment

Research peptide discovered via AI researcher. peptide-based therapeutic

Amylin receptor agonist | Obesity treatment

Eloralintide is a selective amylin receptor agonist that has been investigated for its potential role in the treatment of obesity. The mechanism of action involves the activation of amylin receptors, which are implicated in regulating appetite and glucose metabolism. By mimicking the effects of the naturally occurring hormone amylin, Eloralintide may help reduce food intake and promote weight loss through central nervous system pathways that influence satiety and energy expenditure.

GnRH Antagonist | Prostate cancer treatment

Degarelix is a synthetic peptide that functions as a gonadotropin-releasing hormone (GnRH) antagonist. By competitively inhibiting GnRH receptors in the pituitary gland, degarelix reduces the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This reduction leads to decreased testosterone production in the testes, which is particularly beneficial in the treatment of hormone-sensitive conditions such as prostate cancer, where testosterone can promote tumor growth.

Mitochondrial function | Longevity

Humanin is a mitochondria-derived peptide that has garnered attention for its potential roles in cellular health and longevity. It is encoded by the mitochondrial genome and is involved in various cellular processes, including the regulation of apoptosis, inflammation, and oxidative stress. The peptide has been implicated in protective mechanisms against neurodegenerative diseases and metabolic disorders, suggesting its potential as a therapeutic agent in these conditions.

Modulating appetite | Metabolic disorders

Research peptide discovered via AI researcher. research peptide

Protonophore uncoupler | Metabolic dysfunction

BAM-15 is a mitochondrial protonophore uncoupler studied preclinically for obesity, insulin resistance, and metabolic dysfunction by increasing energy expenditure without raising heart rate.

GLP-1 Agonist | Type 2 Diabetes Management

Albiglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that was developed for the treatment of type 2 diabetes mellitus (T2DM). It mimics the action of the endogenous GLP-1 hormone, which plays a crucial role in glucose metabolism. Albiglutide enhances insulin secretion in response to elevated blood glucose levels, suppresses glucagon secretion, slows gastric emptying, and promotes satiety, contributing to improved glycemic control and potential weight management benefits.

AMPK activator | Metabolic efficiency

AICAR (Acadesine) is a small-molecule compound that acts as an activator of AMP-activated protein kinase (AMPK), a key regulator of cellular energy homeostasis. By mimicking AMP, AICAR promotes a shift in cellular metabolism towards energy-producing pathways, enhancing metabolic efficiency. The activation of AMPK by AICAR has been associated with various physiological effects, including improved endurance, metabolic adaptation, and cardioprotective properties.

Vasopressin analog | Managing fluid balance

Research peptide discovered via AI researcher. peptide-based therapeutic

Metabolic | Glucose metabolism and energy homeostasis

Research peptide discovered via AI researcher. research peptide

NNMT Inhibition | Weight management

Research-peptide often discussed for body recomposition: weight-loss–focused with muscle preservation, cholesterol and inflammation effects.

GHRH analog | Reduces visceral fat in HIV lipodystrophy

Tesamorelin is a synthetic peptide that acts as a growth hormone-releasing hormone (GHRH) analog. It is primarily investigated for its potential to reduce visceral fat in individuals with HIV-associated lipodystrophy, a condition characterized by abnormal fat distribution often exacerbated by antiretroviral therapy. Tesamorelin stimulates the release of endogenous growth hormone, which in turn promotes lipolysis and reduces visceral adipose tissue (VAT) accumulation.

Lipolysis | Fat loss

A GH-fragment–derived peptide primarily discussed for fat loss and body-composition change, sometimes with cartilage and joint-repair context.

Pro-apoptotic | Obesity

Adipotide (Prohibitin-TP01) is an experimental peptidomimetic that targets prohibitin on white adipose vasculature to trigger fat-supply regression, studied preclinically for obesity.

GnRH Agonist | Hormone modulation

Research peptide discovered via AI researcher. peptide analogue

Mitochondrial stabilization | Mitochondrial dysfunction

Research peptide discovered via AI researcher. peptide-based therapeutic

Amylin receptor agonist | Diabetes management

Research peptide discovered via AI researcher. peptide-based therapeutic

Vasodilation | Anti-fibrotic

B7-33 is a single-chain peptide analog of relaxin-2 designed to retain anti-fibrotic and vasodilatory signaling while simplifying synthesis. It is investigational and research-use only.

Bioregulator | Pancreatic endocrine support

Pancragen (KEDW) is a synthetic tetrapeptide bioregulator studied for pancreatic endocrine support, glucose-insulin modulation, and longevity applications in preclinical and small human studies.

GLP-1 Activation | Metabolic Regulation

Research peptide discovered via AI researcher. peptide-based therapeutic

GLP-1 Agonist | Type 2 Diabetes Treatment

Research peptide discovered via AI researcher. peptide-based therapeutic

Gene expression modulation | Liver support

Ovagen (EDL) is a Khavinson-family tripeptide bioregulator researched for liver and gastrointestinal tissue support, proposed to act via gene-expression modulation in hepatocytes and enterocytes.

Receptor Interaction | Metabolic Regulation

Research peptide discovered via AI researcher. research peptide

GLP-1 Agonist | Type 2 Diabetes Management

Research peptide discovered via AI researcher. research peptide

Dual agonist | Metabolic regulation

Research peptide discovered via AI researcher. research peptide

Lipid metabolism | Fat loss

HGH Fragment 176-191, a peptide derived from the C-terminus of human growth hormone (HGH), has been primarily researched for its potential effects on fat loss and metabolic regulation. This peptide is believed to mimic some of the metabolic effects of HGH without the associated growth-promoting side effects. The mechanism of action is thought to involve the modulation of lipid metabolism and glucose uptake in adipocytes, which may contribute to its fat loss properties.

Insulin modulation | Metabolic health

Petrelintide is a synthetic peptide that acts as an analogue of human amylin, a hormone co-secreted with insulin by pancreatic beta cells. Its mechanism of action involves binding to the amylin receptors in the brain and peripheral tissues, which leads to a reduction in appetite, slowing of gastric emptying, and modulation of glucose metabolism. These actions collectively contribute to weight loss and improved metabolic outcomes in individuals with obesity.

Modulation | Experimental research

Research peptide discovered via AI researcher. research peptide

Lipolytic | Fat-burning effects

HGH Fragment 176-191 is a synthetic C-terminal fragment of human growth hormone studied for its lipolytic (fat-burning) effects without the growth-promoting actions of full GH.

Metabolic regulation | Obesity and type 2 diabetes

Research peptide discovered via AI researcher. peptide-based therapeutic

Dual agonist | Metabolic regulation

Research peptide discovered via AI researcher. peptide-based therapeutic

Metabolic regulation | Research peptide

Nisotirostide, also known as LY3457263, is a novel peptide that acts as a selective agonist for the neuropeptide Y2 (NPY2) receptor. This receptor is involved in various physiological processes, including appetite regulation and energy homeostasis. By activating the NPY2 receptor, nisotirostide is hypothesized to influence metabolic pathways that can lead to weight loss and improved glycemic control, making it a potential therapeutic option for conditions such as type 2 diabetes and obesity.

Cellular signaling | Metabolic regulation

Research peptide discovered via AI researcher. research peptide

Stimulates GLP-1 secretion | Appetite regulation

GLP-1 blends refer to combinations of glucagon-like peptide-1 (GLP-1) analogs or related compounds that may enhance the secretion of this hormone, which plays a critical role in glucose metabolism and appetite regulation. Recent research has explored various natural extracts and dietary components that may influence GLP-1 secretion and its physiological effects.

Stimulates GH release | Potential metabolic benefits

GH secretagogue blends are formulations designed to stimulate the secretion of growth hormone (GH) from the pituitary gland. These blends typically consist of various peptides and compounds that may enhance GH release, potentially influencing growth, metabolism, and overall health.

GHRH/GHRP Combination | Growth Hormone Optimization

CJC-1295/Ipamorelin is a research peptide stack pairing a GHRH analog with a selective ghrelin receptor agonist to amplify endogenous growth hormone release.

Four-Peptide Regenerative Blend

KLOW is a four-peptide compounded blend (typically KPV, LL-37, GHK, and Wolverine-style healing peptides) studied informally for combined regenerative and metabolic effects.

GH stimulation | Growth hormone deficiency

Tesamorelin + Ipamorelin GH Secretagogue Blend

Modulating metabolism | Obesity and diabetes

Research peptide discovered via AI researcher. peptide-based therapeutic

Metabolic regulation | Glucose homeostasis

Research peptide discovered via AI researcher. research peptide